These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31983017)

  • 1. The novel TP53 3'-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection.
    Zeng F; Heng J; Guo X; Wang Y; Wu W; Tang L; Chen M; Wang S; Deng H; Wang J
    Breast Cancer Res Treat; 2020 Feb; 180(1):237-245. PubMed ID: 31983017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
    Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
    Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
    Garcia-Closas M; Kristensen V; Langerød A; Qi Y; Yeager M; Burdett L; Welch R; Lissowska J; Peplonska B; Brinton L; Gerhard DS; Gram IT; Perou CM; Børresen-Dale AL; Chanock S
    Int J Cancer; 2007 Dec; 121(11):2532-8. PubMed ID: 17683073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
    Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
    Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DFNA5 promoter methylation a marker for breast tumorigenesis.
    Croes L; de Beeck KO; Pauwels P; Vanden Berghe W; Peeters M; Fransen E; Van Camp G
    Oncotarget; 2017 May; 8(19):31948-31958. PubMed ID: 28404884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
    Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
    Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
    Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
    Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients.
    Heng J; Guo X; Wu W; Wang Y; Li G; Chen M; Peng L; Wang S; Dai L; Tang L; Wang J
    PLoS One; 2017; 12(3):e0174022. PubMed ID: 28301567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.
    Kang JH; Kim SJ; Noh DY; Park IA; Choe KJ; Yoo OJ; Kang HS
    Lab Invest; 2001 Apr; 81(4):573-9. PubMed ID: 11304577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
    O'Sullivan DE; Johnson KC; Skinner L; Koestler DC; Christensen BC
    Epigenetics; 2016 May; 11(5):344-53. PubMed ID: 27070496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients.
    Li Z; Guo X; Wu Y; Li S; Yan J; Peng L; Xiao Z; Wang S; Deng Z; Dai L; Yi W; Xia K; Tang L; Wang J
    Breast Cancer Res Treat; 2015 Feb; 149(3):767-79. PubMed ID: 25636590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of promoter methylation and expression of telomere related genes in breast cancer.
    Heng J; Zhang F; Guo X; Tang L; Peng L; Luo X; Xu X; Wang S; Dai L; Wang J
    Oncotarget; 2017 Apr; 8(15):25442-25454. PubMed ID: 28424414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
    Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
    BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale analysis of
    Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
    Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scrophularia Atropatana Extract Reverses TP53 Gene Promoter Hypermethylation and Decreases Survivin Antiapoptotic Gene Expression in Breast Cancer Cells.
    Ghavifekr Fakhr M; Rezaie Kahkhaie K; Shanehbandi D; Farshdousti Hagh M; Zarredar H; Safarzadeh E; Abdolrahimi Vind M; Baradaran B
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2599-2605. PubMed ID: 30256066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
    BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors.
    Li Z; Chen B; Wu Y; Jin F; Xia Y; Liu X
    BMC Cancer; 2010 Mar; 10():98. PubMed ID: 20230646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Manjegowda MC; Gupta PS; Limaye AM
    Gene; 2017 May; 614():65-73. PubMed ID: 28286086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.